Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

Todd Neale

December 05, 2016

News Daily News

Evidence Supporting Percutaneous or Surgical LAA Exclusion for Stroke Prevention Is Limited, Review Says

Todd Neale

July 14, 2016

News Conference News EuroPCR 2016

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Yael L. Maxwell

May 17, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2016

Shelley Wood

April 29, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Daily News

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

Todd Neale

February 17, 2015

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

Presentation LAA 2014

Safety and Efficacy of the WAVECREST: First-in-Human Experiences and Future Trials

Presenter: Gregg W. Stone

July 19, 2014

Presentation LAA 2014

LARIAT: Clinical Trial Results & Future Trials

Presenter: Steven J. Yakubov

July 19, 2014

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Daily News

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Yael L. Maxwell

April 12, 2013

Advertisement

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

Evidence Supporting Percutaneous or Surgical LAA Exclusion for Stroke Prevention Is Limited, Review Says

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

TCTMD’s Top 10 Most Popular Stories for April 2016

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Safety and Efficacy of the WAVECREST: First-in-Human Experiences and Future Trials

LARIAT: Clinical Trial Results & Future Trials

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content